FLUVABREX
Phase 1 Completed
20 enrolled
CILENT
Phase 1 Completed
32 enrolled
D2C7 for Adult Patients With Recurrent Malignant Glioma
Phase 1 Completed
81 enrolled
Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
Phase 1 Completed
174 enrolled
Study of Orally Administered AG-881 in Patients With Advanced Solid Tumors, Including Gliomas, With an IDH1 and/or IDH2 Mutation
Phase 1 Completed
95 enrolled
Study of AG-120 and AG-881 in Subjects With Low Grade Glioma
Phase 1 Completed
49 enrolled
Feasibility of Individualized Therapy for Recurrent Glioblastoma
Phase 1 Completed
30 enrolled
INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas
Phase 1 Completed
13 enrolled 15 charts
GLIOSPECT
Phase 1 Completed
11 enrolled
EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors
Phase 1 Completed
11 enrolled
ASP8374 + Cemiplimab in Recurrent Glioma
Phase 1 Completed
14 enrolled
HUMC 1612: Optune NovoTTF-200A System
Phase 1 Completed
7 enrolled 12 charts
Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma
Phase 1 Completed
22 enrolled
A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas
Phase 1 Completed
54 enrolled
Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma
Phase 1 Completed
33 enrolled
Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
Phase 1 Completed
17 enrolled 11 charts
AMPLIFY-NEOVAC
Phase 1 Completed
69 enrolled
GMCI
Phase 1 Completed
41 enrolled
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Phase 1 Completed
37 enrolled
Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
Phase 1 Completed
59 enrolled 20 charts
Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma
Phase 1 Completed
28 enrolled
A Dose-Escalation Study in Participants With Recurrent Malignant Glioma
Phase 1 Completed
66 enrolled
Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
Phase 1 Completed
29 enrolled
Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma
Phase 1 Completed
19 enrolled
IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Lower Grade Glioma
Phase 1 Completed
52 enrolled
Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade
Phase 1 Completed
21 enrolled 9 charts
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
Phase 1 Completed
68 enrolled
PBTC-047
Phase 1 Completed
53 enrolled 25 charts
Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children
Phase 1 Completed
8 enrolled 9 charts
ASCR
Phase 1 Completed
14 enrolled
HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors
Phase 1 Completed
13 enrolled
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
Phase 1 Completed
282 enrolled
Stereotactic Radiosurgery in Treating Patients With Brain Tumors
Phase 1 Completed
Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas
Phase 1 Completed
32 enrolled 12 charts
Terameprocol in Treating Patients With Recurrent High Grade Glioma
Phase 1 Completed
20 enrolled
PVSRIPO
Phase 1 Completed
61 enrolled 10 charts
A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors
Phase 1 Completed
8 enrolled
BrTK01
Phase 1 Completed
15 enrolled
Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan In Recurrent High Grade Glioma
Phase 1 Completed
18 enrolled
EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas
Phase 1 Completed
22 enrolled
Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
Phase 1 Completed
10 enrolled
Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma
Phase 1 Completed
30 enrolled
Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors
Phase 1 Completed
6 enrolled
CED With Irinotecan Liposome Injection Using Real Time Imaging in Children With Diffuse Intrinsic Pontine Glioma (DIPG) (PNOC 009)
Phase 1 Completed
6 enrolled
A Study of PRT811 in Participants With Advanced Solid Tumors, CNS Lymphoma and Gliomas
Phase 1 Completed
86 enrolled
SAS-GKRS
Phase 1 Completed
24 enrolled
Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma
Phase 1 Completed
12 enrolled 13 charts
Hypofractionated Stereotactic Irradiation With Nivolumab, Ipilimumab and Bevacizumab in Patients With Recurrent High Grade Gliomas
Phase 1 Completed
33 enrolled
A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)
Phase 1 Completed
19 enrolled
Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma
Phase 1 Completed
20 enrolled